Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Dec. 31, 2025. Document 2025-24123. Updated Nov. 16, 2026.
- What it does
The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What changed in the regulation
2 parts of Title 21, 42 of the Code of Federal Regulations:
Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).
- Compared with
The Drug Enforcement Administration has published 27 final rules in 2026 so far, compared with 17 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- Before this
5 earlier Federal Register documents under regulation identifier 1117-AB40, 1117-AB78, 1117-ZA07 since Jan. 1, 2025.
- March 24, 2025 Final rule. Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
- Feb. 19, 2025 Final rule; delay of effective dates and request for comments. Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
- Jan. 17, 2025 Notice of proposed rulemaking. Special Registrations for Telemedicine and Limited State Telemedicine Registrations
- Jan. 17, 2025 Final rule. Expansion of Buprenorphine Treatment via Telemedicine Encounter
- Jan. 17, 2025 Final rule. Continuity of Care via Telemedicine for Veterans Affairs Patients
- What happens next and when
This rule is effective January 1, 2026 through December 31, 2026.
The agency's dates, word for word.
Reginfo.gov lists a rule with this regulation identifier as under review at the White House Office of Information and Regulatory Affairs since Aug. 25, 2026 (stage: Final Rule). See it
The record as published
| Document number | 2025-24123 |
|---|---|
| Action | Temporary rule. |
| Agencies | Justice Department; Drug Enforcement Administration; Health and Human Services Department |
| Published | Dec. 31, 2025 |
| Effective date | Jan. 1, 2026 |
| Regulation identifier (RIN) | 1117-AB40, 1117-AB78, 1117-ZA07 |
| Docket | HHS-OS-2025-0001 |
| Significant (marked in the Federal Register) | Yes |
Source: the Federal Register (public domain). The document in the Federal Register